Longeveron (LGVN) Interest Coverage Ratio (QoQ) (2020 - 2026)
Longeveron (LGVN) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Longeveron | 14.77 Bn | 14.76 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02% |
| Dec 31, 2025 | -27.11% |
| Sep 30, 2025 | -30.28% |
| Jun 30, 2025 | 2.99% |
| Mar 31, 2025 | 11.19% |
| Dec 31, 2024 | 78.62% |
| Sep 30, 2024 | 72.13% |
| Jun 30, 2024 | -307.84% |
| Mar 31, 2024 | 89.60% |
| Dec 31, 2023 | -661.64% |
| Sep 30, 2023 | 4.00% |
| Jun 30, 2023 | -19,238.42% |
| Mar 31, 2023 | -100.03% |
| Dec 31, 2022 | 1,986.10% |
| Sep 30, 2022 | -285.11% |
| Jun 30, 2022 | -24.37% |
| Mar 31, 2022 | -5,967.66% |
| Dec 31, 2021 | 130.24% |
| Sep 30, 2021 | 19.25% |
| Jun 30, 2021 | -56.14% |